❌

Normal view

FlyPrompt: Brain-Inspired Random-Expanded Routing with Temporal-Ensemble Experts for General Continual Learning

arXiv:2602.01976v3 Announce Type: replace-cross Abstract: General continual learning (GCL) challenges intelligent systems to learn from single-pass, non-stationary data streams without clear task boundaries. While recent advances in continual parameter-efficient tuning (PET) of pretrained models show promise, they typically rely on multiple training epochs and explicit task cues, limiting their effectiveness in GCL scenarios. Moreover, existing methods often lack targeted design and fail to address two fundamental challenges in continual PET: how to allocate expert parameters to evolving data distributions, and how to improve their representational capacity under limited supervision. Inspired by the fruit fly's hierarchical memory system characterized by sparse expansion and modular ensembles, we propose FlyPrompt, a brain-inspired framework that decomposes GCL into two subproblems: expert routing and expert competence improvement. FlyPrompt introduces a randomly expanded analytic router for instance-level expert activation and a temporal ensemble of output heads to dynamically adapt decision boundaries over time. Extensive theoretical and empirical evaluations demonstrate FlyPrompt's superior performance, achieving up to 11.23%, 12.43%, and 7.62% gains over state-of-the-art baselines on CIFAR-100, ImageNet-R, and CUB-200, respectively. Our source code is available at https://github.com/AnAppleCore/FlyGCL.

Spatial Omics in Gastrointestinal Oncology: Recent Advances, Therapeutic Insights, and Clinical Translation

J Cancer. 2026 Jan 30;17(3):515-523. doi: 10.7150/jca.127381. eCollection 2026.

ABSTRACT

Gastrointestinal (GI) cancers remain a leading cause of cancer-related morbidity and mortality worldwide, largely due to their molecular heterogeneity, complex tumor microenvironment (TME), and variable treatment responses. In recent years, the emergence of spatially resolved omics technologies-encompassing spatial transcriptomics, proteomics, metabolomics, and epigenomics-has revolutionized the ability to interrogate tumor architecture with unprecedented resolution. These methods enable precise mapping of cellular and molecular interactions within intact tissue contexts, thereby uncovering spatially defined niches that influence tumor progression, immune evasion, and therapeutic resistance. In GI malignancies such as colorectal, gastric, and esophageal cancers, spatial omics have provided critical insights into cancer-stromal-immune crosstalk, identified predictive biomarkers for immunotherapy and targeted agents, and guided the development of novel therapeutic strategies. This review synthesizes the latest advances in spatial omics applied to GI oncology over the past five years, with an emphasis on their integration into early diagnosis, treatment stratification, and real-time monitoring of therapeutic efficacy. We also discuss current challenges, including standardization, data integration, and clinical validation, as well as future directions for incorporating spatial profiling into routine oncology practice. By bridging the gap between bench discoveries and bedside applications, spatial omics hold transformative potential for achieving truly personalized treatment in gastrointestinal cancers.

PMID:41869445 | PMC:PMC13003551 | DOI:10.7150/jca.127381

❌